Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis.
Anthony J LemboWilliam D CheyLucinda A HarrisRosita FrazierDarren M BrennerLin ChangBrian E LacySusan EdelsteinYang YangSuling ZhaoDavid P RosenbaumPublished in: The American journal of gastroenterology (2024)
Tenapanor significantly reduced abdominal symptoms in patients with irritable bowel syndrome with constipation, particularly pain, discomfort, and bloating measured by AS, compared with placebo.